AlphaMadera

CareTrust REIT, Inc. (CTRE)

Stock NYSE

$37.81

-0.80 (-2.07%)

Delayed quote.

Price history

Daily close
CTRE daily closing price, Nov 12, 2025 to Nov 11, 2026 Closed at $36.20 on Nov 12, 2025 and $38.61 on Nov 11, 2026, a change of +6.66%. Range $35.45 to $43.39.
Daily closes, Nov 12, 2025 to Nov 11, 2026 (251 trading days).
Start
$36.20
Latest close
$38.61
Period change
+6.66%
Period low
$35.45
Period high
$43.39

Key metrics

Market cap
$9.74B
Volume
3.99M
Average volume
2.39M
52-week range
$34.74 – $43.62
Beta
0.79
Last dividend
$1.50
EPS (TTM)
$1.61
P/E ratio
23.48
Revenue (TTM)
$615.54M
Net income (TTM)
$364.15M
Total assets
$7.71B
Total debt
$2.07B
Cash and equivalents
$479.88M

Key financials (trailing twelve months).

Company profile

CareTrust REIT, Inc. operates as a self-managed, publicly traded real estate investment trust. The company specializes in the ownership, acquisition, development, and leasing of various healthcare properties, including skilled nursing facilities, seniors' housing complexes, and other related medical real estate. It maintains a broad, nationwide portfolio of assets, all under long-term net lease agreements with an expanding group of reputable operators. CareTrust REIT is actively pursuing strategic growth across the United States, leveraging both external investments and organic expansion opportunities.

Sector
Real Estate
Industry
REIT - Healthcare Facilities
Exchange
NYSE
CEO
David Sedgwick
Employees
43
Headquarters
Dana Point, CA, US
IPO date
2014-05-29
Website
https://www.caretrustreit.com

Financial statements

Annual, last 3 fiscal years. Most recent period first. Reported in USD.

Income statement
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Revenue$476.59M$228.26M$198.60M
Gross profit$281.79M$214.71M$189.01M
Operating income$320.14M$124.06M$116.00M
EBITDA$462.04M$211.64M$145.86M
Net income$320.54M$125.08M$53.73M
Diluted EPS$1.57$0.80$0.50
Balance sheet
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Cash and equivalents$198.04M$213.82M$294.45M
Total assets$5.15B$3.44B$2.08B
Total liabilities$1.09B$507.63M$666.12M
Total debt$894.22M$396.93M$595.60M
Shareholders’ equity$4.04B$2.91B$1.42B
Cash flow statement
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Operating cash flow$394.03M$244.25M$154.77M
Capital expenditure-$14.99M-$8.05M-$10.98M
Free cash flow$379.04M$236.20M$143.79M

Quarterly, last 6 quarters. Most recent period first. Reported in USD.

Income statement
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Revenue$176.36M$161.35M$142.78M$135.05M$104.27M$86.03M
Gross profit$167.76M$150.79M$81.17M$79.58M$101.66M$82.98M
Operating income$109.96M$104.30M$93.01M$86.57M$59.55M$49.21M
EBITDA$136.08M$136.54M$122.45M$152.69M$111.59M$102.30M
Net income$83.65M$89.00M$80.21M$111.29M$74.90M$68.55M
Diluted EPS$0.35$0.38$0.36$0.52$0.35$0.35
Balance sheet
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Cash and equivalents$479.88M$49.27M$223.21M$198.04M$712.48M$306.05M
Total assets$7.71B$5.93B$5.24B$5.15B$5.09B$4.66B
Total liabilities$2.34B$1.42B$1.08B$1.09B$1.07B$1.33B
Total debt$2.07B$1.21B$894.65M$894.22M$893.79M$1.16B
Shareholders’ equity$5.33B$4.49B$4.13B$4.04B$3.99B$3.30B
Cash flow statement
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Operating cash flow$154.88M$134.75M$90.36M$120.96M$100.91M$100.78M
Capital expenditure-$3.48M-$4.27M-$3.16M-$4.98M-$3.23M-$4.51M
Free cash flow$151.41M$130.48M$87.20M$115.98M$97.68M$96.27M